AnalystsJack SlevinJack Slevin's Stock Forecasts
AnalystsJack Slevin
Analyst Ranking
Top 37%
#2046 out of 5550 analysts
Average Return
+19.96%
Win Rate
86%6 out of 7
Risk vs Reward
Poor
Good
Jack Slevin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Astrana Health IncASTH | +57.32% | $23.22 | $36.53 | 2025-11-25 - 2026-10-30 | Strong Buy |
Pediatrix Medical Group IncMD | +43.84% | $11.36 | $16.34 | 2024-09-26 - 2025-09-25 | Strong Buy |
Agilon Health IncAGL | +39.96% | $60.66 | $84.90 | 2026-05-07 - 2026-10-30 | Strong Buy |
Pediatrix Medical Group IncMD | +39.58% | $15.36 | $21.44 | 2024-11-05 - 2025-11-04 | Strong Buy |
Covista IncCVSA | +11.97% | $105.08 | $117.66 | 2025-04-23 - 2026-04-22 | Strong Buy |
Jack Slevin Analyst Color
Get additional color on Jack Slevin's coverage of popular stocks
Jack Slevin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Concentra Group Holdings Parent IncCON | 1 | Strong Buy | $47.00 | +16.39% | Initiates Coverage On | 15 days ago |
Pediatrix Medical Group IncMD | 3 | Hold | $28.00 | -6.10% | Downgrades | 2 months ago |
Agilon Health IncAGL | 2 | Strong Buy | $48.00 | -43.46% | Upgrades | 6 months ago |
Astrana Health IncASTH | 1 | Strong Buy | $37.00 | +1.29% | Maintains | a year ago |
Covista IncCVSA | 1 | Strong Buy | $135.00 | N/A | Initiates Coverage On | 2 years ago |
Starling Oncology IncSTLN | 1 | Strong Buy | $2.50 | N/A | Assumes | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.